PHARMACELL
Board
1 director, since incorporationDirector
since 09-12-2019
term without a fixed end
listed in the 2025 annual accounts, filed on 26-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 13-12-2019
Mandates through the years
1 name, the dashed line is todayDirector
Board
Mandates as a list
-
- Director, from 09-12-2019 to date
Control
Founder
This company
PHARMACELL
Equity €494,200
Profit €223,035 in 2025
Capital
- Contribution
- €300,000
- Shares
- 1,000
- Contribution per share
- €300
- Equity per share
- €494 in 2025
- Source
- deed of 13-12-2019
Articles of association
deed of 13-12-2019 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 11:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten genoemd in artikel 2:87 WVV zonder bijzondere machtiging algemene vergadering, desgevallend voor te leggen aan voorzitter…”
Founder
At incorporation
deed of 13-12-2019 ↗
- sole founder · 100% at incorporation